Donor-derived cell-free DNA as a diagnostic tool in transplantation
There is a need to improve personalized immunosuppression in organ transplantation to reduce premature graft loss. Biomarkers are needed to better detect rejection, asymptomatic graft injury, and under-immunosuppression. Assessment of minimal necessary exposure to guide tapering and prevent immune a...
Main Authors: | Michael Oellerich, Klemens Budde, Bilgin Osmanodja, Kirsten Bornemann-Kolatzki, Julia Beck, Ekkehard Schütz, Philip D. Walson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.1031894/full |
Similar Items
-
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
by: Bilgin Osmanodja, et al.
Published: (2023-03-01) -
Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
by: K Denhaerynck, et al.
Published: (2014-01-01) -
Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies
by: Jin Zhang, et al.
Published: (2019-12-01) -
The natural history of de novo donor-specific HLA antibodies after kidney transplantation
by: Covadonga López del Moral, et al.
Published: (2022-09-01) -
The relation between zero-time pretransplant deceased donor renal biopsy and kidney transplant survival
by: Tavakkoli M, et al.
Published: (2019-04-01)